Shares of newly public Metsera (NASDAQ:MTSR), which is developing ultra-long-acting obesity drugs, rallied 54% following a ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

The widespread acceptance of the so-called GLP-1 drugs, Zepbound by Eli Lilly and Wegovy by Novo Nordisk, for weight loss has created a game-changing dynamic for the overall health of the 72% of ...

Both of these GLP-1 drugs were originally designed for diabetes, but their benefits keep expanding — KSTP health expert Dr.

More than 69.2 million FDA-approved weight-loss prescriptions were dispensed in the U.S. from July 2017 through February 2024 ...

By Dr. Arshpreet Saraan Weight loss injectables have been making headlines in the papers and across social media the past couple of years, but how much do we really know about them?   Ozempic, Wegovy, ...

Check out the tense Storebound teaser trailer for this upcoming co-op survival horror game set in a furniture store with a terrifying creature on the prowl. The Storebound teaser trailer shows the ...

The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...

In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond ...

The portraits were taken by Trump's chief photographer, Daniel Torok. While Trump's official portrait from his first presidency depicts him smiling broadly, the expression on his face in his new ...

The Biden administration has said that the last round of talks lowered the amount that Medicare paid for some drugs by 40% to 80% versus their official ... weight loss drug, Zepbound, seems ...